|
|
Research Publications:
Janes PW, Griesshaber B, Atapattu L, Nievergall E, Hii LL, Mensinga A, Chheang C, Day BW, Boyd AW, Bastianens PI, Jorgensen C, Pawson T, and Lackmann M. Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. J Cell Biol. Accepted Nov 2011.
Day BW, Stringer BW, Spanevello MD, et al. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neuro Oncology. 2011 Aug 16.
Ting MJ, Day BW, Spanevello MD, Boyd AW. Activation of ephrin A proteins influences Hematopoietic Stem Cell Adhesion and Trafficking patterns. Exp Hematol. 2010 Jul 22.
McCarron JK, Stringer BW, Day BW, Boyd AW. Ephrin expression and function in cancer. Future Oncol. 2010 Jan;6(1):165-76.
Stringer B, Day BW, McCarron J, Lackmann M, Boyd A . EPHA3 (EPH receptor A3). Atlas Genet Cytogenet Oncol Haematol. April 2009.
Day BW, Smith FM, Chen K, McCarron JK, Herath NI, Lackmann M, Boyd AW. Eph/Ephrin membrane proteins: a mammalian expression vector pTIg-BOS-Fc allowing rapid protein purification.Protein Pept Lett. 2006;13(2):193-6.
Day BW, To C, Himanen JP, Smith FM, Nikolov DB, Boyd AW, Lackmann M. Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J Biol Chem. 2005 Jul 15;280(28):26526-32.
|